C106H113F4N21O11 — CID 158519668
1-[4-(cyanomethyl)-1-[[4-(cyclopenten-1-yl)phenyl]methyl]-3-fluoropiperidin-4-yl]-3-(2-cyclopropyl-2-oxoethyl)pyrazole-4-carboxamide;1-[4-(cyanomethyl)-1-[(4-ethynylphenyl)methyl]-3-fluoropiperidin-4-yl]-3-(cyclopropanecarbonylamino)pyrazole-4-carboxamide;methyl 2-[4-carbamoyl-1-[4-(cyanomethyl)-3-fluoro-1-[(2-fluoro-3-hydroxy-4-phenylphenyl)methyl]piperidin-4-yl]pyrazol-3-yl]acetate;methyl 2-[4-carbamoyl-1-[1-(cyanomethyl)-4-(4-phenylanilino)cyclohexyl]pyrazol-3-yl]acetate (PubChem CID 158519668) has the molecular formula C106H113F4N21O11 and a molecular weight of 1933.20 g/mol. Its IUPAC name is 1-[4-(cyanomethyl)-1-[[4-(cyclopenten-1-yl)phenyl]methyl]-3-fluoropiperidin-4-yl]-3-(2-cyclopropyl-2-oxoethyl)pyrazole-4-carboxamide;1-[4-(cyanomethyl)-1-[(4-ethynylphenyl)methyl]-3-fluoropiperidin-4-yl]-3-(cyclopropanecarbonylamino)pyrazole-4-carboxamide;methyl 2-[4-carbamoyl-1-[4-(cyanomethyl)-3-fluoro-1-[(2-fluoro-3-hydroxy-4-phenylphenyl)methyl]piperidin-4-yl]pyrazol-3-yl]acetate;methyl 2-[4-carbamoyl-1-[1-(cyanomethyl)-4-(4-phenylanilino)cyclohexyl]pyrazol-3-yl]acetate.
| Compound Name | 1-[4-(cyanomethyl)-1-[[4-(cyclopenten-1-yl)phenyl]methyl]-3-fluoropiperidin-4-yl]-3-(2-cyclopropyl-2-oxoethyl)pyrazole-4-carboxamide;1-[4-(cyanomethyl)-1-[(4-ethynylphenyl)methyl]-3-fluoropiperidin-4-yl]-3-(cyclopropanecarbonylamino)pyrazole-4-carboxamide;methyl 2-[4-carbamoyl-1-[4-(cyanomethyl)-3-fluoro-1-[(2-fluoro-3-hydroxy-4-phenylphenyl)methyl]piperidin-4-yl]pyrazol-3-yl]acetate;methyl 2-[4-carbamoyl-1-[1-(cyanomethyl)-4-(4-phenylanilino)cyclohexyl]pyrazol-3-yl]acetate |
|---|---|
| PubChem CID | 158519668 |
| Molecular Formula | C106H113F4N21O11 |
| Molecular Weight | 1933.20 g/mol |
| Exact Mass | 1931.89 |
| IUPAC Name | 1-[4-(cyanomethyl)-1-[[4-(cyclopenten-1-yl)phenyl]methyl]-3-fluoropiperidin-4-yl]-3-(2-cyclopropyl-2-oxoethyl)pyrazole-4-carboxamide;1-[4-(cyanomethyl)-1-[(4-ethynylphenyl)methyl]-3-fluoropiperidin-4-yl]-3-(cyclopropanecarbonylamino)pyrazole-4-carboxamide;methyl 2-[4-carbamoyl-1-[4-(cyanomethyl)-3-fluoro-1-[(2-fluoro-3-hydroxy-4-phenylphenyl)methyl]piperidin-4-yl]pyrazol-3-yl]acetate;methyl 2-[4-carbamoyl-1-[1-(cyanomethyl)-4-(4-phenylanilino)cyclohexyl]pyrazol-3-yl]acetate |
| SMILES | C#Cc1ccc(CN2CCC(CC#N)(n3cc(C(N)=O)c(NC(=O)C4CC4)n3)C(F)C2)cc1.COC(=O)Cc1nn(C2(CC#N)CCC(Nc3ccc(-c4ccccc4)cc3)CC2)cc1C(N)=O.COC(=O)Cc1nn(C2(CC#N)CCN(Cc3ccc(-c4ccccc4)c(O)c3F)CC2F)cc1C(N)=O.N#CCC1(n2cc(C(N)=O)c(CC(=O)C3CC3)n2)CCN(Cc2ccc(C3=CCCC3)cc2)CC1F |
| InChI | InChI=1S/C28H32FN5O2.C27H27F2N5O4.C27H29N5O3.C24H25FN6O2/c29-26-18-33(16-19-5-7-21(8-6-19)20-3-1-2-4-20)14-12-28(26,11-13-30)34-17-23(27(31)36)24(32-34)15-25(35)22-9-10-22;1-38-23(35)13-21-20(26(31)37)15-34(32-21)27(9-11-30)10-12-33(16-22(27)28)14-18-7-8-19(25(36)24(18)29)17-5-3-2-4-6-17;1-35-25(33)17-24-23(26(29)34)18-32(31-24)27(15-16-28)13-11-22(12-14-27)30-21-9-7-20(8-10-21)19-5-3-2-4-6-19;1-2-16-3-5-17(6-4-16)13-30-12-10-24(9-11-26,20(25)15-30)31-14-19(21(27)32)22(29-31)28-23(33)18-7-8-18/h3,5-8,17,22,26H,1-2,4,9-12,14-16,18H2,(H2,31,36);2-8,15,22,36H,9-10,12-14,16H2,1H3,(H2,31,37);2-10,18,22,30H,11-15,17H2,1H3,(H2,29,34);1,3-6,14,18,20H,7-10,12-13,15H2,(H2,27,32)(H,28,29,33) |
| InChIKey | HMBGQWSXDCOINV-UHFFFAOYSA-N |
| XLogP | 13.18 |
| TPSA | 479.55 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 142 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1933.20 |
| LogP ≤ 5 | 13.18 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 27 |
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|